Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel Whittam, Brigitte Wildemann, Klaus Berek et al.|Multiple Sclerosis and Related Disorders|2020Cited by 179
Smoking is a risk factor for early conversion to clinically definite multiple sclerosisFranziska Di Pauli, Thomas Berger, Markus Reindl et al.|Multiple Sclerosis Journal|2008Cited by 141
Restoring immune tolerance in neuromyelitis opticaAmit Bar‐Or, Kevin C. O’Connor, Jacinta M. Behne et al.|Neurology Neuroimmunology & Neuroinflammation|2016Cited by 57
Restoring immune tolerance in neuromyelitis opticaKevin C. O’Connor, Amit Bar‐Or, Jacinta M. Behne et al.|Neurology Neuroimmunology & Neuroinflammation|2016Cited by 42